Event JSON
{
"id": "3c3e58b52e803fef2565c963c6232342924c44d723bcd86150d5f05ee5027f3b",
"pubkey": "9c41d1165a76eda7abb3db9d665e67fdd23320dd1a8c6a65ff40a65935d667cc",
"created_at": 1739188952,
"kind": 1,
"tags": [
[
"r",
"https://www.cnbc.com/2025/02/10/trump-could-make-changes-to-medicare-drug-price-negotiations.html"
],
[
"subject",
"Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma"
],
[
"published_at",
"1739188801"
],
[
"image",
"https://image.cnbcfm.com/api/v1/image/108096275-1738586589508-gettyimages-2196133108-AFP_36WR46H.jpeg?v=1738599443\u0026w=1920\u0026h=1080"
],
[
"p",
"9c41d1165a76eda7abb3db9d665e67fdd23320dd1a8c6a65ff40a65935d667cc",
"wss://articles.layer3.news"
],
[
"imeta",
"url https://image.cnbcfm.com/api/v1/image/108096275-1738586589508-gettyimages-2196133108-AFP_36WR46H.jpeg?v=1738599443\u0026w=1920\u0026h=1080"
],
[
"t",
"mainstream:perspective"
],
[
"summary",
"The article discusses President Trump's potential approach to the Medicare drug price negotiation process, which was established by the Inflation Reduction Act. While Trump is unlikely to eliminate the process, he may make changes to it, potentially benefiting the pharmaceutical industry. The changes could include altering the selection criteria for drugs, revising the guidelines for negotiations, and potentially introducing new stakeholders to the process. The article also mentions the ongoing legal fight between manufacturers and the federal government over the program, and the potential for Trump to take a different approach to defending the program in court."
]
],
"content": "nostr:nprofile1qyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpqn3qaz9j6wmk602anmwwkvhn8lhfrxgxar2xx5e0lgzn9jdwkvlxqy56fv4\nhttps://image.cnbcfm.com/api/v1/image/108096275-1738586589508-gettyimages-2196133108-AFP_36WR46H.jpeg?v=1738599443\u0026w=1920\u0026h=1080\nTrump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper savings to outdo his predecessor.\nhttps://www.cnbc.com/2025/02/10/trump-could-make-changes-to-medicare-drug-price-negotiations.html",
"sig": "7e35636bbd8a6127fe372a6a99e3840755de66332f7dcac1cd64263f14359da68fa0a41c847aa7b139910a865f3895c0a5908b92c2dc085f6200eced1fb62ec0"
}
